These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9411052)

  • 1. [Immunoglobulin G monoclonal human anti-rhesus Rho(D) to prevent rhesus-incompatibility].
    Olovnikova NI; Belkina EV; Drize NI; Konopliannikov AG; Lemeneva LN; Miterev GIu; Nikolaeva TL; Savel'eva GM; Chertkov IL
    Klin Med (Mosk); 1997; 75(7):39-43. PubMed ID: 9411052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A human anti-D monoclonal antibody selected for enhanced FcgammaRIII engagement clears RhD+ autologous red cells in human volunteers as efficiently as polyclonal anti-D antibodies.
    Beliard R; Waegemans T; Notelet D; Massad L; Dhainaut F; Romeuf Cd; Guemas E; Haazen W; Bourel D; Teillaud JL; Prost JF
    Br J Haematol; 2008 Apr; 141(1):109-19. PubMed ID: 18279459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: more questions than answers.
    Kumpel BM
    Vox Sang; 2007 Aug; 93(2):99-111. PubMed ID: 17683353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of human monoclonal IgG and IgM antibodies with anti-D (rhesus) specificity using heterohybridomas.
    Thompson KM; Melamed MD; Eagle K; Gorick BD; Gibson T; Holburn AM; Hughes-Jones NC
    Immunology; 1986 May; 58(1):157-60. PubMed ID: 3011653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immuno-elimination and clearance of Rh-positive erythrocytes in Rh-negative volunteers following administration of anti-D-immunoglobulin].
    Maas DH; Weitzel HK; Stolp W; Hünermann B; Schneider J
    Geburtshilfe Frauenheilkd; 1983 Mar; 43(3):164-70. PubMed ID: 6305763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn.
    Nielsen LK; Green TH; Sandlie I; Michaelsen TE; Dziegiel MH
    Transfusion; 2008 Jan; 48(1):12-9. PubMed ID: 17764508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-D human immunoglobulin: new preparation. Important in young Rh D (-) women.
    Prescrire Int; 2001 Feb; 10(51):4-7. PubMed ID: 11503859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic basis and immunoprophylaxis of RhD induced hemolytic disease of the newborn (HDN).
    Payam Khaja Pasha R; Shokri F
    Iran J Immunol; 2008 Dec; 5(4):189-200. PubMed ID: 19098362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional in vitro studies of recombinant human immunoglobulin G and immunoglobulin A anti-D.
    Nielsen LK; Green TH; Norderhaug L; Sandlie I; Dziegiel MH
    Transfusion; 2007 Feb; 47(2):306-15. PubMed ID: 17302778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal anti-D immunoglobulin for prevention of hemolytic disease of the newborn].
    Olovnikova NI; Belkina EV; Berkovskiĭ AL; Lemeneva LN; Nikolaeva TL; Chertkov IL
    Gematol Transfuziol; 1994; 39(4):3-6. PubMed ID: 7875519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND
    Methods Mol Biol; 2008; 444():185-201. PubMed ID: 18425481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antenatal Rh prophylaxis is unnecessary for "Asia type" DEL women.
    Shao CP; Xu H; Xu Q; Sun GD; Li JP; Zhang BW; Liang XH; Liu Z; Zhou Y; Li D; Zhuang NB
    Transfus Clin Biol; 2010 Oct; 17(4):260-4. PubMed ID: 20961786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of D(u) phenotype amongst rhesus negative females in Port Harcourt, Nigeria.
    Nwauche CA; Ejele OA; Okpani AO
    Afr J Reprod Health; 2003 Apr; 7(1):27-31. PubMed ID: 12816311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro functional test of two subclasses of an anti-RhD antibody produced by transient expression in COS cells.
    Nielsen LK; Norderhaug L; Sandlie I; Dziegiel MH
    APMIS; 2006 May; 114(5):345-51. PubMed ID: 16725010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gel agglutination test--a new test system for semiquantitative detection of feto-maternal transfusion in Rhesus incompatibility].
    David M; Stelzer A; Wittmann G; Dudenhausen JW; Salama A
    Z Geburtshilfe Neonatol; 1999; 203(6):241-5. PubMed ID: 10612196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal RhD genotyping: a more efficient use of anti-D immunoglobulin.
    Daniels G; Finning K; Martin P; Summers J
    Transfus Clin Biol; 2007 Dec; 14(6):568-71. PubMed ID: 18436463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An increased risk for non allo-immunization related intrauterine fetal death in RhD-negative patients.
    Ben-David G; Sheiner E; Levy A; Erez O; Mazor M
    J Matern Fetal Neonatal Med; 2008 Apr; 21(4):255-9. PubMed ID: 18330822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Massive fetomaternal hemorrhage and prevention of fetomaternal Rhesus incompatibility. The failure of our present system of prevention].
    Quartier P; Floch C; Meier F; Fruchart MF; Brossard Y; Lejeune C
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):517-9. PubMed ID: 8228016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylatic rhesus sensitization via intravenous administration of immunoglobulin G anti-D. III. Limits of the prophylaxsis obtainable by adapting the immunoglobulin dosage to the extent of the fetalmaternal blood transfusion (author's transl)].
    Börner P; Deicher H; Bähr I; Chalius HH; Ghani G; Geldmacher H; Henke IW; Kindermann L; Marks V
    Geburtshilfe Frauenheilkd; 1976 Jun; 36(6):485-92. PubMed ID: 820591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economics of routine antenatal anti-D prophylaxis for pregnant women who are rhesus negative.
    Chilcott J; Tappenden P; Lloyd Jones M; Wight J; Forman K; Wray J; Beverley C
    BJOG; 2004 Sep; 111(9):903-7. PubMed ID: 15327602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.